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Abstract: Phosphorylation of alcohols by phosphoryl chlorides catalyzed by pyridine-N-oxide is reported. The utility of this method is 
demonstrated through phosphorylation of primary, secondary and a tertiary alcohol as well as phenols under mild reaction conditions and 
with low catalyst loading (5 mol%). 
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Phosphorylation of alcohol groups in e.g. peptides, 
proteins, inositols, glycerols and steroids plays a 
pivotal role in many physiologically important 
processes.1 Disease states including cancers and 
immune system disorders are often characterized by 
perturbation of these processes.2,3 Phosphate 
derivatives are also commonly prepared in order to 
increase the aqueous solubility of alcohols e.g. in pro-
drugs.4–6 The development of synthetic methods for 
the efficient, cost-effective and scalable 
phosphorylation of alcohol derivatives is therefore an 
important goal. 
Alcohol phosphorylation (i.e. phosphate mono-ester 
formation) by direct acid catalyzed condensation with 
phosphoric acid is generally difficult to control for 
structurally diverse alcohols.7 Consequently, 
phosphorylation is more generally achieved either by 
phosphitylation then oxidation/deprotection [i.e. using 
a P(III) reagent e.g. a phosphoramidite] or by direct 
phosphorylation then deprotection [i.e. using a P(V) 
reagent e.g. dialkoxychlorophosphate].8 
Phosphitylation reactions tend to be faster than 
phosphorylation reactions but require the substrate to 
display stability to the subsequent oxidation. Direct 
phosphorylation can be achieved with Brønsted/Lewis 
acid or nucleophilic catalysis. For example, Jones et 
al. have used Ti(OtBu)4, TiCl4 or Cu(OTf)2 with 
phosphoryl chlorides9,10 and N-phosphoryl 
oxazolidinones,11–13 and more recently, Sculimbrene et 
al. have reported the use of Ti(OtBu)4 with 
pyrophosphates.14,15 Pyridine,16 4-DMAP17 and 
DABCO18 have been used as super-stoichiometric 
nucleophilic promotors of phosphorylation and Miller 
et al. have deployed N-methylimidazole (NMI)19 and 
4-DMAP20 sub-stoichiometrically with phosphoryl 
chlorides (Figure 1). 
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Figure 1. Catalytic methods for phosphorylation of alcohols. 
Whilst the Lewis acid catalyzed methods have 
demonstrated good substrate scope and are moderate 
to high yielding, separation of the metal catalysts from 
the products can be problematic and costly e.g. in late 
stage pharmaceutical synthesis.21–24 The existing 
organonucleophile catalyzed processes do not appear 
to have been systematically investigated but our 
experience indicates that their scope/efficacy is 
inferior to the procedure described herein. 
Pyridine-N-oxides have been used extensively as 
nucleophilic catalysts for the coupling of 3’-
phosphorylated nucleotides with 5’-OH nucleotides in 
the synthesis of oligonucelotides25,26 and we have 
recently reported the use of 2-aryl-4-
(dimethylamino)pyridine-N-oxides as catalysts for the 
chemoselective phosphorylation of α-amino acid 
derivatives, polyols and peptides.27 During the course 
of these studies, it was noted that pyridine-N-oxide 
itself provided significant rate enhancement in alcohol 
phosphorylation reactions using phosphoryl chlorides. 
Herein, we report the use of pyridine-N-oxide as a 
competent nucleophilic catalyst for the 
phosphorylation of hydroxyl containing substrates 
using phosphoryl chlorides. 
Our initial studies focused on evaluation of bases for 
the phosphorylation of 4-phenyl-1-butanol (1) by 
diphenyl phosphoryl chloride (DPPCl) using pyridine-
N-oxide (2) as a catalyst (Table 1). 
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Table 1 Phosphorylation of 4-phenyl-1-butanol. 
DPPCl (1.1 eq.)
Base (2 eq.)
2 h, RT, CH2Cl2 (0.2 M)
N
O
Ph
OH
2
(5 mol%) Ph
O
P
O
OPh
OPh
1a 3a
 
Entry Catalyst Base Conv. (%)a 
1 None None 0 
2 2 None 0 
3 2 PPO 47 
4 2 PS© >99 (98)b 
5 2 NEt3 87 
6 2 PMP >99 
7 None PS© 0 
aConversion to product 3 as determined by 1H NMR of the crude 
reaction mixture. bIsolated yield after chromatographic 
purification. PPO = propylene oxide, PS© = 1,8-bis(NMe2)-
naphthalene (Proton Sponge©), PMP = 1,2,2,6,6-
pentamethylpiperidine. 
In the absence of base and/or catalyst no reaction was 
observed (entries 1, 2 and 7, Table 1). Whilst 
propylene oxide provided moderate levels of 
conversion (entry 3, Table 1), both Proton Sponge© 
and PMP provided quantitative conversion within 2 h 
(entries 4, 6, Table 1). With the aim of developing a 
general method for the economic and scalable 
phosphorylation of alcohols, Proton Sponge© was 
identified as optimal and these conditions were 
applied to a variety of alcohol substrates (Table 2). 
Table 2 Pyridine-N-oxide catalyzed phosphorylation - substrate 
scope. 
DPPCl (1.1 eq.)
PS©
 
(2 eq.)
RT, CH2Cl2 (0.2 M)
Time
N
O
(5 mol%)
1b-i 3b-i
R1OH R1O
P
O
OPh
OPh
 
Entry Product Compound # 
Time 
(h) Yield (%)
a 
1 
 
3b 2 98 
2 
 
3c 8 94 
3 
 
3d 8 ~81b 
4 
 
3e 24 57 
5 
 
3f 1 95 (17)c 
6 
 
3g 1 97 (21)c 
7 
 
3h 1 91 (14)c 
8 
 
3i 1 82 (7)c 
aIsolated yield after chromatographic purification. bProduct 3d 
decomposes on silica gel (cf. 9,14), impurities present, see 
Supporting Information. cConversion to product 3 as 
determined by 1H NMR of the crude reaction mixture of the 
uncatalyzed reaction. 
Benzyl alcohol was phosphorylated in good yield 
within 2 h (entry 1, Table 2). Secondary alcohols and 
tert-BuOH were also phosphorylated with moderate to 
good yields, albeit with increased reactions times 
(entries 2-4, Table 1). Other tertiary alcohols (e.g. α-
terpineol and 2-phenyl-2-propanol) were unreactive to 
these conditions. Phenols were converted to 
phosphorylated products in high yields and short 
reaction times (1 h), irrespective of the electronics of 
other aryl substituents (entries 5-8, Table 2). Although 
these phenols are also phosphorylated in the absence 
of catalyst, rates are significantly increased in the 
presence of the pyridine-N-oxide catalyst. 
Having established reaction conditions that appeared 
general for the phosphorylation of a range of hydroxyl 
containing substrates, including the preparation of 
phosphoryl derivatives known to be highly sensitive 
to adventitious nucleophiles (e.g. compounds 3b and 
3d), phosphorylation of a selection of biologically 
relevant molecules and phosphate ester pro-drugs was 
evaluated (Table 3). 
Table 3 Phosphorylation of biologically relevant molecules and 
phosphate pro-drugs. 
R1OH
N
O
(5 mol%)
Phosphoryl chloride (1.1 eq.)
PS© (2 eq.)
RT, CH2Cl2 (0.2 M)
Time
o-XPCl
Cl O
O
P
O
O O
O
P
O
R1
or
R1O
P
O
OPh
OPh
 
Entry Product Compound # Time (h) 
Yield 
(%)a 
1 
 
4 2  85 
2 
 
5a R = Ph 1 74 (27)b 
5b R,R = o-XP 1 71 (15)b 
3 
 
6 2 83 
4 
 
7 2 61 
5 
 
8 2 77 (74)c 
6 
 
9 8 54 
7 
 
10a R = Ph 1 91 (59)b 
10b R,R =o-XP 1 93 (21)b 
aIsolated yield after chromatographic purification. bConversion to 
product as determined by 1H NMR of the crude reaction mixture of the 
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uncatalyzed reaction. cYield of reaction conducted on 20 mmol scale 
with respect to alcohol. 
The allylic alcohol geraniol was phosphorylated in 
good yield within 2 h (entry 1, Table 3). Steroid 
derivatives containing phenolic and primary alcohols 
were also phosphorylated in good yield and with 
chemoselectivity over secondary and tertiary hydroxyl 
functionalities (entries 2 and 3, Table 3). 
Phosphorylation of the primary 5’-OH group of 
adenosine in the presence of the 2’ and 3’-OH groups 
was also achieved (entry 4, Table 3); phosphorylation 
of the 2’ and 3’-OH groups was not detected (by 31P 
NMR). Phosphorylation of protected amino-acid 
residues Ser, Thr and Tyr was also achieved in 
moderate to good yields (entries 5-7, Table 3). 
Phosphorylation of Boc-Ser(OH)-OMe was also 
conducted on a 20 mmol (5 g) scale with comparable 
yield in the same timescale (entry 5, Table 3). 
For the phosphorylation of the phenolic substrates,28 
o-xylenyl phosphoryl chloride (o-XPCl) was also 
employed in place of DPPCl (entries 2 and 7, Table 
3).29 This allows for selective deprotection by 
hydrogenolysis (H2/Pd-C)27,30 or with acid (e.g. 
HBr/AcOH),31 which cannot be achieved for phenyl 
phosphate esters (or for products containing other 
phenyl moieties).31–33 Thus, deprotection of 
phosphates 5b and 8 by hydrogenolyis yielded the 
corresponding phosphates quantitatively (Scheme 1). 
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Scheme 1. Deprotection of phosphate esters 5b and 8. 
To probe the mechanism of catalysis operating in the 
phosphorylation reactions, a 1:1 mixture of pyridine-
N-oxide and DPPCl was analysed by NMR in CDCl3. 
1H and 31P NMR spectra of this mixture revealed 
complete conversion of both starting materials to a 
new species in which the pyridyl C2/C6 protons had 
shifted by ΔδH = +0.28 ppm and the phosphorus signal 
by ΔδP = -20.32 ppm, suggesting the formation of an 
O-phosphorylated salt as expected during nucleophilic 
catalysis (Figure 2). 
Figure 2 The aromatic regions of 1H NMR spectra of pyridine-N-
oxide (upper) and the proposed intermediate salt (lower). The 
peaks at δH ~8.3 ppm and ~8.6 ppm are the C2/C6 protons. 
Subsequent treatment of this salt with an alcohol 
results in rapid conversion to the phosphate mono-
ester product. Our attempts to obtain crystals of the 
intermediate salt, suitable for single crystal X-ray 
structure determination, have however so far been 
unsuccessful. 
In conclusion, we have demonstrated the use of 
pyridine-N-oxide as an effective and economical 
organocatalyst for the phosphorylation of primary and 
secondary alcohols and phenols, including several 
biologically relevant molecules. The reaction times 
and yields are comparable to those described for 
Lewis acid catalyzed conditions and superior to those 
of previously described simple nucleophilic 
organocatalysts (e.g. 4-DMAP and NMI). This 
method therefore provides a complimentary approach 
to catalytic phosphoryl transfer that obviates the need 
for metal catalysts and which may therefore be of 
particular utility in the late-stage production of 
phosphate esters for biological applications, e.g. in the 
preparation of pro-drugs. For difficult alcohol 
phosphorylation cases, e.g. the site selective 
phosphorylation of polyols, the use of a 2-aryl-4-
DMAP-N-oxide catalyst will likely be warranted,27 
but the commercial availability and low cost of 
pyridine-N-oxide makes it an attractive first choice 
catalyst for evaluation. 
Supporting Information for this article is available 
online at http://www.thieme-
connect.com/products/ejournals/journal/10.1055/s-
00000083. 
Primary Data for this article are available online at 
http://www.thieme-
connect.com/products/ejournals/journal/10.1055/s-
00000083 and can be cited using the following DOI: 
(number will be inserted prior to online publication). 
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